Judge SJ, Malekzadeh P, Corines MJ, Gollub MJ, Horvat N, Gonen M, Saltz L, Cercek A, Romesser P, Crane C, Shia J, Wei I, Widmar M, Pappou E, Nash GM, Smith JJ, Paty PB, Garcia-Aguilar J, Weiser MR. Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy. JNCI: Journal of the National Cancer Institute. 2024,Nov;116:1761-1766. PMCID:PMC11542991

Bektas AB, Hakki L, Khan A, Widmar M, Wei IH, Pappou E, Smith JJ, Nash GM, Paty PB, Garcia-Aguilar J, Cercek A, Stadler Z, Segal NH, Shia J, Gonen M, Weiser MR. Clinical calculator for predicting freedom from recurrence after resection of stage I-III colon cancer in patients with microsatellite instability. JCO Clinical Cancer Informatics. 2024,Sep;8:e2300233. PMCID:PMC11323037

Hakki L, Khan A, Do E, Gonen M, Firat C, Vakiani E, Shia J, Widmar M, Wei IH, Smith JJ, Pappou EP, Nash GM, Paty PB, Garcia-Aguilar J, Weiser MR. Tumour deposits are independently associated with recurrence in colon cancer. Colorectal Disease. 2024,Mar;26:459-465. PMCID:PMC10981558

Khan A, Thompson HM, Hsu M, Widmar M, Wei IH, Pappou E, Smith JJ, Nash GM, Paty PB, Garcia-Aguilar J, Shia J, Gönen M, Weiser M. Validation of a clinical calculator predicting freedom from colon cancer recurrence after surgery on the basis of molecular and clinical variables . Diseases of the Colon and Rectum. 2024,Feb;67:240-245. PMCID:PMC10843082

Hakki L, Khan A, Gonen M, Stadler Z, Segal NH, Shia J, Widmar M, Wei IH, Smith JJ, Pappou EP, Nash GM, Paty PB, Garcia-Aguilar J, Weiser MR. Lymph node metastases and associated recurrence-free survival in microsatellite stable and unstable colon cancer. Annals of Surgical Oncology. 2023,Dec;30:8487-8494. PMCID:PMC10842299

Ooi GJ, Narasimhan V, Weiser MR. Two-surgeon dual-console robotic low anterior resection with selective lateral lymph node dissection—A video vignette. Colorectal Disease. 2024,Jan;26:214-216. PMCID:PMC10842756

Hakki L, Khan A, Ehrich F, Thompson HM, Sokolowski S, Gonen M, Aviki EM, Weiser MR. Younger patients with colon cancer are more likely to experience financial toxicity than older patients. Annals of Surgical Oncology. 2023,Oct;30:6837-6842. PMCID:PMC10527083

Schrag D, Qian S, Weiser MR, Gollub MJ, Saltz LB, Musher BL, Goldberg J, Al Baghdadi T, Goodman KA, McWilliams RR, Farma JM, George TJ, Kennecke HF, Shergill A, Montemurro M, Nelson GD, Colgrove B, Gordon V, Venook AP, O’Reilly EM. Preoperative treatment of locally advanced rectal cancer. New England Journal of Medicine. 2023,Jul;389:322-334. PMCID:PMC10775881

Keshinro A, Ganesh K, Vanderbilt C, Firat C, Kim JK, Chen CT, Yaeger R, Segal NH, Gonen M, Shia J, Stadler ZK, Weiser MR. Characteristics of mismatch repair-deficient colon cancer in relation to mismatch repair protein loss, hypermethylation silencing, and constitutional and biallelic somatic mismatch repair gene pathogenic variants. Diseases of the Colon and Rectum. 2023,Apr;66:549-558. PMCID:PMC9763548

Weiser MR, Chou JF, Kim JK, Widmar M, Wei IH, Pappou EP, Smith JJ, Nash GM, Paty PB, Cercek A, Saltz LB, Romesser PB, Crane CH, Garcia-Aguilar J, Schrag D, Gonen M. A dynamic clinical calculator for estimating conditional recurrence-free survival after total neoadjuvant therapy for rectal cancer and either surgery or watch-and-wait management. JAMA Network Open. 2022,Sep;5:e2233859. PMCID:PMC9523500

Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, El Dika IH, Segal N, Shcherba M, Sugarman R, Stadler Z, Yaeger R, Smith JJ, Rousseau B, Argiles G, Patel M, Desai A, Saltz LB, Widmar M, Iyer K, Zhang J, Gianino N, Crane C, Romesser PB, Pappou EP, Paty P, Garcia-Aguilar J, Gonen M, Gollub M, Weiser MR, Schalper KA, Diaz L. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. New England Journal of Medicine. 2022,Jun;386:2363-2376. PMCID:PMC9492301

Kim JK, Chen CT, Keshinro A, Khan A, Firat C, Vanderbilt C, Segal N, Stadler Z, Shia J, Balachandran VP, Weiser MR. Intratumoral T-cell repertoires in DNA mismatch repair-proficient and -deficient colon tumors containing high or low numbers of tumor-infiltrating lymphocytes. OncoImmunology. 2022,Jan;11:e2054757. PMCID:PMC9037499

Weiser MR, Chou JF, Keshinro A, Chapman W, Bauer PS, Mutch MG, Parikh PJ, Cercek A, Saltz LB, Gollub MJ, Romesser PB, Crane CH, Shia JR, Markowitz AJ, Garcia-Aguilar J, Gonen M, for the Colorectal Cancer Disease Management Team of Memorial Sloan Kettering Cancer Center. Development and assessment of a clinical calculator for estimating the likelihood of recurrence and survival among patients with locally advanced rectal cancer treated with chemotherapy, radiotherapy, and surgery. JAMA Network Open. 2021,Nov;4:e2133457. PMCID:PMC857658

Weiser MR, Hsu M, Bauer PS, Chapman W, GonzaÌlez IA, Chatterjee D, Lingam D, Mutch MG, Keshinro A, Shia J, Vakiani E, Konishi T, Shimada Y, Stadler Z, Segal NH, Cercek A, Saltz L, Yaeger R, Varghese A, Widmar M, Wei IH, Pappou EP, Smith JJ, Nash G, Paty P, Garcia-Aguilar J, Gonen M. Clinical calculator based on molecular and clinicopathologic characteristics predicts recurrence following resection of stage I-III colon cancer. Journal of Clinical Oncology. 2021,Mar;39:911-919. PMCID:PMC8189618

Keshinro A, Vanderbilt C, Kim JK, Firat C, Chen CT, Yaeger R, Ganesh K, Segal NH, Gonen M, Shia J, Stadler Z, Weiser MR. Tumor-infiltrating lymphocytes, tumor mutational burden, and genetic alterations in microsatellite unstable, microsatellite stable, or mutant POLE/POLD1 colon cancer. JCO Precision Oncology. 2021,Jan;5:817-826. PMCID:PMC8232557

Jimenez-Rodriguez RM, Patil S, Keshinro A, Shia J, Vakiani E, Stadler Z, Segal NH, Yaeger R, Konishi T, Shimada Y, Widmar M, Wei I, Pappou E, Smith JJ, Nash G, Paty P, Garcia-Aguilar J, Weiser MR. Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer. OncoImmunology. 2020,Jan;9:1841948. PMCID:PMC7671050

Roxburgh CSD, Strombom P, Lynn P, Cercek A, Gonen M, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Shia J, Vakiani E, Yaeger R, Stadler ZK, Segal NH, Reidy D, Varghese A, Wu AJ, Crane CH, Gollub MJ, Saltz LB, Garcia-Aguilar J, Weiser MR. Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomes. Colorectal Disease. 2019,Oct;21:1140-1150. PMCID:PMC6773478

Roxburgh CSD, Strombom P, Lynn P, Gonen M, Paty PB, Guillem JG, Nash GM, Smith JJ, Wei I, Pappou E, Garcia-Aguilar J, Weiser MR. Role of the interval from completion of neoadjuvant therapy to surgery in postoperative morbidity in patients with locally advanced rectal cancer. Annals of Surgical Oncology. 2019,Jul;26:2019-2027. PMCID:PMC6579536

Konishi T, Shimada Y, Hsu M, Wei IH, Pappou E, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, Cercek A, Yaeger R, Stadler ZK, Segal NH, Varghese A, Saltz LB, Shia J, Vakiani E, Gönen M, Weiser MR. Contemporary validation of a nomogram predicting colon cancer recurrence, revealing all-stageimproved outcomes. JNCI Cancer Spectrum. 2019,Jun;3:pkz015. PMCID:PMC6512350

Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Yaeger R, Stadler ZK, Seier K, Gonen M, Segal NH, Reidy DL, Varghese A, Shia J, Vakiani E, Wu AJ, Crane CH, Gollub MJ, Garcia-Aguilar J, Saltz LB, Weiser MR. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncology. 2018,Jun;4:e180071. PMCID:PMC5885165

Konishi T, Shimada Y, Lee LH, Cavalcanti MS, Hsu M, Smith JJ, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Vakiani E, Gonen M, Shia J, Weiser MR. Poorly differentiated clusters predict colon cancer recurrence: An in-depth comparative analysis of invasive-front prognostic markers. American Journal of Surgical Pathology. 2018,Jun;42:705-714. PMCID:PMC5943141

Roxburgh CS, Shia J, Vakiani E, Daniel T, Weiser MR. Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer. OncoImmunology. 2018,Jan;7:e1435227. PMCID:PMC5980419

Konishi T, Shimada Y, Hsu M, Tufts L, Jimenez-Rodriguez R, Cercek A, Yaeger R, Saltz L, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, Gonen M, Weiser MR. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome. JAMA Oncology. 2018,Mar;4:309-315. PMCID:PMC5885834